Today, 02:30 AM
Frederick Health (Frederick, MD) recently launched a first-of-its-kind precision medicine integration that enhances their decision support capabilities with intuitive recommendations that are tailored to the individual patient and their cancer’s specific characteristics. The integration between MEDITECH’s Expanse Genomics solution and GenomOncology's Precision Oncology Platform expands access to comprehensive precision medicine information within their Expanse EHR, including Expanse Oncology.
In the first six months, Frederick Health recorded 96 patients who received a treatment change based on the advanced recommendations that target the genetics of each patient’s individual cancer. In the same six months, clinical trial referrals have skyrocketed, with Frederick Health noting 56 new referrals to their own clinical trials program. Read the full press release here and see a video from Frederick Health about genomics.
Learn more about the Expanse Genomics solution and GenomOncology Precision Oncology integration in a 30-minute on-demand webinar where MEDITECH’s Manager of Clinical Product Management Jennifer Ford, and GenomOncology’s Vice President of Product Innovation James Cole, PhD, dive into how our integrated solutions empower clinicians and researchers to develop impactful treatment strategies.
Hear directly from Frederick Health at HIMSS25, where Clinical Director of Precision Medicine and Genetics Patricia Rice, and Vice President and CIO Jackie Rice will present Expanding Use Cases for Genomics: A Precision Medicine Update. Patricia will also participate in a panel discussion, “Patient-Driven Healthcare: How EHR Technology is Fueling the Precision Medicine Revolution,” in MEDITECH Booth #972 on Tuesday, March 4, at 11:30 a.m.
To learn more about Frederick Health's success with Expanse Genomics, download the case study Frederick Health Streamlines Genetic Test Ordering and Result Processes by Over 50% Using Expanse Genomics.
In the first six months, Frederick Health recorded 96 patients who received a treatment change based on the advanced recommendations that target the genetics of each patient’s individual cancer. In the same six months, clinical trial referrals have skyrocketed, with Frederick Health noting 56 new referrals to their own clinical trials program. Read the full press release here and see a video from Frederick Health about genomics.
Learn more about the Expanse Genomics solution and GenomOncology Precision Oncology integration in a 30-minute on-demand webinar where MEDITECH’s Manager of Clinical Product Management Jennifer Ford, and GenomOncology’s Vice President of Product Innovation James Cole, PhD, dive into how our integrated solutions empower clinicians and researchers to develop impactful treatment strategies.
Hear directly from Frederick Health at HIMSS25, where Clinical Director of Precision Medicine and Genetics Patricia Rice, and Vice President and CIO Jackie Rice will present Expanding Use Cases for Genomics: A Precision Medicine Update. Patricia will also participate in a panel discussion, “Patient-Driven Healthcare: How EHR Technology is Fueling the Precision Medicine Revolution,” in MEDITECH Booth #972 on Tuesday, March 4, at 11:30 a.m.
To learn more about Frederick Health's success with Expanse Genomics, download the case study Frederick Health Streamlines Genetic Test Ordering and Result Processes by Over 50% Using Expanse Genomics.